Abstract:Imidazo[1,2-a]pyridine derivatives are a kind of fused heterocyclic substances, which play an important role in the chemical field and have been proved to be the core fragments of various drug molecules. In this study, a new title compound was finally synthesized by cyclization, substitution, Suzuki coupling, hydrolysis and condensation. And the crystal of the title compound was obtained by single crystal culture. The structure of 2-(2-chloro-6-(m-tolyl)imidazo[1,2-a]pyridin-3-yl)-N,N-diethylacetamide was confirmed by 1H NMR, 13C NMR, FT-IR and single crystal X-ray diffraction. In addition, the title compound was theoretically calculated at the level of 6–311+G (2d, p) based on density functional method B3LYP, and the molecular structure optimized by DFT was consistent with the results obtained by X-ray diffraction. By calculating the Hirschfield surfaces and 2D fingerprints of molecules, the interactions between molecules can be visually revealed based on the size and color of the spots near the atoms. In addition, according to the characteristic vibration absorption band, the vibration of the title compound is reliably attributed. Furthermore, MEP, RDG, and ELF analyses were conducted to characterize the reaction sites susceptible to electrophilic and nucleophilic attacks. FMOs was used to evaluate the stability of the molecular structure. Finally, the results of the determination of biological activity showed that the compound exhibited significant inhibitory activity against HCT116 cancer cell.

Novel amino pyridine compound, its preparation method, pharmaceutical composition containing compound and application thereof

Antitumor compound, synthesis method and applications thereof

Design, Synthesis, and Biological Evaluation of Novel Phenol Ether Derivatives As Non-Covalent Proteasome Inhibitors.

Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives

Pyrimidine ring containing quinolone derivatives as well as preparation method and application thereof

Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors

Discovery of (R)-5-((5-(1-methyl-1h-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a Novel CHK1 Inhibitor for Hematologic Malignancies.

1-(3-aminopropyl) piperazine-4-aminoamide compound as well as preparation method and application thereof

New Application of Novel Tetrazine Derivatives As Potent VEGFR-2 Kinase Inhibitors and Anti-Cancer Agents

Synthesis, bioevaluation and molecular dynamics of pyrrolo-pyridine benzamide derivatives as potential antitumor agents in vitro and in vivo

Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors

Triphenylmethyl compounds, preparation method and applications thereof

Structure-guided design and development of novel N-phenylpyrimidin-2-amine derivatives as potential c-Met inhibitors

Synthesis and Anti-Tumor Efficacy of Novel 2, 4-Diarylaminopyrimidine Derivatives Bearing N-(3-pyridinylmethyl) Urea Moiety As Anaplastic Lymphoma Kinase Inhibitors.

Novel 5-(benzyloxy)pyridin-2(1H)-one derivatives as potent c-Met inhibitors

Synthesis, crystal structure, DFT, vibrational properties, Hirshfeld surface and antitumor activity studies of a new compound 2-(2-chloro-6-(m-tolyl)imidazo[1,2-a]pyridin-3-yl)-N,N-diethylacetamide

Synthesis And Evaluation Of Novel 2,4-Diaminopyrimidines Bearing A Sulfoxide Moiety As Anaplastic Lymphoma Kinase (Alk) Inhibition Agents

Design, Synthesis and Evaluation of Novel Diaryl Urea Derivatives As Potential Antitumor Agents.

Pyridazinone Derivatives Displaying Highly Potent and Selective Inhibitory Activities Against C-Met Tyrosine Kinase.

Design, Synthesis and Biological Evaluation of 4-Phenoxy- Pyridine/Pyrimidine Derivatives as Dual VEGFR-2/c-Met Inhibitors

Design, synthesis and biological evaluation of 4-(4-aminophenoxy)picolinamide derivatives as potential antitumor agents